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The importance of T helper type 1 (Th1) cell immunity
in host resistance to the intracellular bacterium Fran-
cisella tularensis is well established. However, the
relative roles of interleukin (IL)-12-Th1 and IL-23-
Th17 cell responses in immunity to F. tularensis
have not been studied. The IL-23-Th17 cell pathway
is critical for protective immunity against extracel-
lular bacterial infections. In contrast, the IL-23-Th17
cell pathway is dispensable for protection against
intracellular pathogens such as Mycobacteria. Here
we show that the IL-23-Th17 pathway regulates the
IL-12-Th1 cell pathway and was required for protec-
tive immunity against F.tularensis live vaccine strain.
We show that IL-17A, but not IL-17F or IL-22, induced
IL-12 production in dendritic cells and mediated Th1
responses. Furthermore, we show that IL-17A also
induced IL-12 and interferon-g production in macro-
phages and mediated bacterial killing. Together,
these findings illustrate a biological function for
IL-17A in regulating IL-12-Th1 cell immunity and
host responses to an intracellular pathogen.
INTRODUCTION
Francisella tularensis, the causative agent of tularemia, is a facul-
tative intracellular bacterium, classified by the U.S. Center for
Disease Control as a category A agent of bioterrorism (Dennis
et al., 2001). Routes of infection include contact, ingestion, or
inhalation, with inhalation considered the most likely route of
bioterrorism because of the severe disease caused by low doses
of airborne bacteria (<10 colony forming units [CFU]) (Dennis
et al., 2001). A F. tularensis live vaccine strain (LVS) has been
developed from a F. tularensis B strain and has potential for
use as a vaccine, but it is currently not licensed for use inhumans. In mice, F. tularensis LVS causes disease that is similar
to human tularemia and is used to study the immune compo-
nents required for protection against tularemia (Duckett et al.,
2005).
The importance of interferon gamma (IFN-g) and T helper type
1 (Th1) cell responses in immunity to F. tularensis infection is well
established (Anthony et al., 1989; Duckett et al., 2005). Inter-
leukin-12 (IL-12), made up of IL-12p35 (encoded by the Il12a
gene) and IL-12p40 (encoded by the Il12b gene) subunits, is crit-
ical for the induction of IFN-g production from T and natural killer
(NK) T cells (Trinchieri et al., 2003). Il12a/ mice are susceptible
to respiratory F. tularensis LVS infection and exogenous IL-12
treatment increases survival (Duckett et al., 2005). IL-23 is also
composed of the p40 subunit, and p19 (encoded by the Il23a
gene), a four-a helix molecule (Oppmann et al., 2000), and is
required for maintenance of T helper type 17 (Th17) cell
responses (Dong, 2006). Th17 cells produce IL-17A, the related
cytokine IL-17F, IL-21, and IL-22 (Ouyang et al., 2008) and are
involved in the induction of inflammation and tissue destruction
associated with models of autoimmune diseases (Langrish
et al., 2005). Conversely, IL-23-dependent IL-17 responses are
important for protective immunity against extracellular bacterial
infections for optimal induction of chemokines, recruitment of
neutrophils, and bacterial killing (Happel et al., 2005; Ye et al.,
2001). However, Th17 cell cytokines appear to be dispensable
for protection against most intracellular infections examined so
far. For example, mice deficient in the IL-23-Th17 cell pathway
are resistant to Mycobacteria (Khader et al., 2005; Umemura
et al., 2007; Aujla et al., 2008), Listeria (Aujla et al., 2008), and
Salmonella infections (Schulz et al., 2008). Nevertheless,
in vitro infection of human monocytes with the virulent strain of
F. tularensis SCHU S4 induces IL-23 (Butchar et al., 2007).
Further, pulmonary infection with F. tularensis LVS induces
Th17 cells in the lung (Woolard et al., 2008), suggesting that
Th17 cells may play a role in immunity to F. tularensis.
In light of these data, the goal of this study was to define the
relative roles of IL-12-Th1 and IL-23-Th17 cell pathways in
immunity to pulmonary F. tularensis LVS infection. Our dataImmunity 31, 799–810, November 20, 2009 ª2009 Elsevier Inc. 799
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pathogen infections (Khader et al., 2005; Aujla et al., 2008), the
IL-23-Th17 cell pathway plays a unique role in protection against
F. tularensis LVS pulmonary infection. We show that IL-17A, but
not IL-17F or IL-22, induced IL-12 production in DCs and medi-
ated protective Th1 cell responses. Further, we also show that
IL-17A induced IL-12 and IFN-g in macrophages and enhanced
clearance of F. tularensis LVS. Our data therefore suggest that
the IL-23-Th17 cell pathway is critical for optimal induction of
Th1 cell responses and protection against F. tularensis LVS.
RESULTS
IL-12p40 Cytokine Members Are Induced in the Lung
in Response to F. tularensis LVS Infection
To determine whether IL-12p40 cytokines were induced in the
lung during pulmonary tularemia, we infected wild-type C57BL/
6 (B6) mice intratracheally with F. tularensis LVS and found that
IL-23p19 mRNA was induced at day 2, with lower induction
between days 4 and 6 (Figure 1A). However, induction of
IL-12p35 and IL-12p40 mRNA was detected at day 2 and
γ
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B Figure 1. IL-12-Dependent IFN-g Is Critical
for Protection after Pulmonary Tularemia
mRNA induction for IL-23p19, IL-12p35 and
IL-12p40 (A) and IFN-g, IL-17A, and INOS (B) in
F. tularensis LVS-infected B6 lungs versus unin-
fected lungs was determined by RT-PCR. B6 and
Il12b/ mice (C), B6, Il12a/.Il23a/, and
Il12rb1/ mice (D), and B6, Il12a/, and Ifng/
mice (E) were infected with F. tularensis LVS and
the lung cfu was determined. Lung homogenates
were assayed for IFN-g (F) or IL-17A (G) expres-
sion. Data points represent the mean (±SD) from
4–5 mice (A–G). **p % 0.005 and ***p % 0.0005.
One experiment is representative of two or more.
maintained through days 4–6 (Figure 1A).
Intracellular killing of F. tularensis LVS by
activated macrophages is dependent on
IFN-g-dependent inducible nitric oxide
synthase (iNOS) (Lindgren et al., 2005).
We found induction of IFN-g and IL-17A
mRNA between days 2 and 4, which
coincided with induction of iNOS mRNA
(Figure 1B). These data indicate that
F. tularensis LVS induced IL-12p40,
IL-12 and IL-23 in the infected lung and
implicate both the IL-23-Th17 and IL-12-
Th1 cell pathway in host responses to
F. tularensis LVS.
IL-12-Dependent IFN-g Is Critical
for Protection after Pulmonary
F. tularensis LVS Infection
To determine whether there was a pro-
tective role for IL-12p40-dependent
cytokines in control of F. tularensis LVS
infection, we infected B6 mice, mice lack-
ing all IL-12p40 cytokines (Il12b/)
(Figure 1C), Il12rb1/ mice, and mice lacking both IL-12p35
and IL-23p19 subunits (Il12a/.Il23a/) (Figure 1D) with
F. tularensis LVS and determined CFU in infected lungs. Il12b/,
Il12rb1/, and Il12a/ Il23a/ mice had higher lung CFU when
compared to B6 mice (Figures 1C and 1D) and did not survive
past day 8, whereas all B6 infected mice survived (Figure S1
available online and data not shown). Further, we found that
both Ifng/ and Il12a/ mice also had substantially higher
lung CFU compared to B6 mice (Figure 1E). Interestingly, all
Ifng/ mice did not survive past day 6, whereas Il12a/ mice
survived until day 8 after infection (Figure S1). Also, Il12a/
mice had lower lung CFU when compared to Ifng/ mice, sug-
gesting other IL-12p40-dependent IL-12-independent mecha-
nisms of protection. IFN-g protein was induced in infected B6
lungs, but the absence of IL-12p40, IL-12RB1, and IL-12 and
IL-23 cytokines resulted in a profound defect in the induction
of lung IFN-g (Figure 1F). Il12a/mice displayed a similar reduc-
tion in IFN-g production, indicating that of the IL-12p40 cytokine
members, IL-12 is critical for generation of Th1 cell immunity
during F. tularensis LVS infection. Further, MHC class II expres-
sion on lung CD11c+ cells was upregulated in B6 infected mice,800 Immunity 31, 799–810, November 20, 2009 ª2009 Elsevier Inc.
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Figure 2. IL-23-Dependent IL-17A Is Required for Protection against Pulmonary Tularemia
B6 and Il23a/ mice were infected with F. tularensis LVS and the lung cfu was determined (A). Lung IL-17A amounts (B) and the number of lung IL-17A-producing
cells from day 4-infected B6 and Il23a/ mice was determined (C). B6, Il17a/, and Il17ra/ mice were infected with F. tularensis LVS, and lung cfu was deter-
mined (D). F. tularensis LVS-infected B6 mice were treated with either control or IL-17A neutralizing antibody, and lung cfu was determined (E). B6, Il22/, and
Tcrd T cell-deficient mice (F) were infected with F. tularensis LVS, and lung cfu was determined. Data points represent the mean (±SD) from 4–5 mice (A–F). *p%
0.05, **p% 0.005, and ***p% 0.0005. ns, not significant. One experiment representative of two or more.but was ablated in gene-deficient infected lungs (Figures S2A
and S2B). Also, absence of IFN-g ablated the induction of inflam-
matory molecules including TNF-a, IL-1a, IL-b, and MIP1a in
infected Ifng/ lungs (Figure S2C). These data demonstrate
that IL-12 is required for induction of IFN-g responses and that
IFN-g responses coincide with activation of lung CD11c+ cells
and control of pulmonary F. tularensis LVS infection.
IL-17A Is Induced in the F. tularensis LVS-Infected lungs
and Is Negatively Regulated by IFN-g
Because IL-17A mRNA (Figure 1B) and IL-17A protein was
induced in infected B6 lungs (Figure 1G), we determined whether
this was dependent on IL-12p40 cytokines. As expected, the
IL-17A amounts were ablated in the absence of IL-12p40 and
IL-12RB1 and greater in the absence of IL-12 and IFN-g
(Figure 1G). Further, the major producers of IL-17A in the lungs
of F. tularensis LVS-infected mice were antigen dependent
(Figure S3A). However, we also detected IL-17A-producing cells
in the wells that did not receive antigen (Figure S3A), suggesting
other cellular sources, such as gamma delta (gd) T cells (Ume-
mura et al., 2007) and NK T cells (Lee et al., 2008). Although
IL-12p40 and IL-12RB1 were required for the induction of
IL-17A-producing cells in infected mice, there was no substantial
increase in the total number of IL-17A-producing cells detected
in the Ifng/- and Il12a/-infected lungs when compared to B6
lungs (Figure S3A). These data suggest that the higher amounts
of lung IL-17A protein in Ifng/ and Il12a/ mice (Figure 1G)
was likely due to a higher production of IL-17A on a per cell basis.
IL-17A is known to induce chemokines such as granulocyte
stimulating factor (G-CSF) and granulocyte-macrophage stimu-
lating factor (GM-CSF) (Ouyang et al., 2008), and we found thatG-CSF, GM-CSF, keratinocyte chemoattractant (KC), and
monocyte chemoattractant protein (MCP)-1 levels were all
substantially higher in Ifng/ infected lungs when compared
to B6 mice (Figure S3B). These data demonstrate that IL-17A
is induced in the lung after F. tularensis LVS infection and that
IFN-g negatively regulates IL-17A responses during pulmonary
tularemia. However, high amounts of IL-17A in the absence of
Th1 cell immunity fails to confer protection against F. tularensis
LVS infection.
IL-23-Dependent IL-17A Is Required for Protection
against Pulmonary Tularemia
The IL-23-IL-17 axis is dispensable for protection against
studied intracellular pathogens (Khader et al., 2005; Umemura
et al., 2007; Aujla et al., 2008). Interestingly, when challenged
with F. tularensis LVS, the Il23a/ mice had higher lung CFU
(Figure 2A), which correlated with decreased lung IL-17A expres-
sion (Figure 2B) and number of lung IL-17A-producing cells
(Figure 2C). Further, both Il17a/ and Il17ra/ mice had higher
lung CFU compared to B6 mice (Figure 2D) and did not survive
past day 10 after infection (Figure S1). In addition, neutralization
of IL-17A in F. tularensis LVS-infected B6 mice increased lung
CFU when compared to isotype control-treated B6 mice
(Figure 2E).
IL-22, another cytokine produced by Th17 cells, induces
production of antimicrobial peptides for host defense against
extracellular bacteria (Aujla et al., 2008; Zheng et al., 2008).
Surprisingly, Il22/ mice were not more susceptible than B6
mice and had comparable lung CFU to B6 mice (Figure 2F). gd
T lymphocytes are one of the major producers of IL-17A
in response to intracellular pathogen infections (UmemuraImmunity 31, 799–810, November 20, 2009 ª2009 Elsevier Inc. 801
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deficient mice had substantially higher CFU (Figure 2F) and
decreased induction of lung IL-17A when compared to B6
mice (B6 mice 55.8 ± 14.5, Tcrd T cell-deficient mice 35.8 ±
7.9, p value = 0.050). These data demonstrate that IL-17A but
not IL-22 is critical for protection against pulmonary tularemia
and that both conventional T cells and gd T cells are likely cellular
sources of IL-17A.
IL-17A Is Required for Induction of IFN-g Responses
during Pulmonary Tularemia
A role for IL-17A in the induction of G-CSF and recruitment of
neutrophils is well documented (Ye et al., 2001). Accordingly,
G-CSF amounts were substantially decreased in Il17a/ and
Il17ra/ infected lungs (Figure 3A), which correlated with
a decrease in the percentage of neutrophils (Figure 3B and
Figure S4A) and cellular infiltrates (Figures S4B and S4C). None-
theless, Il17a/ and Il17ra/ mice still recruited significant
percentages of neutrophils to the lungs when compared to
uninfected lungs (p value = 0.0002, < 0.0001 respectively)
(Figure 3B). Therefore, we next determined whether the absence
of IL-17A or IL-17R impacted induction of protective molecules
such as TNF-a (Leiby et al., 1992) and IFN-g (Duckett et al.,
2005) in infected lungs. Although induction of TNF-awas compa-
rable (Figure 3C), IFN-g expression was substantially reduced in
the lungs of infected Il17a/ and Il17ra/ mice (Figure 3D). As
expected, IL-17A expression was elevated in the Il17ra/
infected lungs (Smith et al., 2008) (Figure 3E). Although IFN-g
and IL-12p35 mRNA are induced in the infected B6 lungs,
reduced induction of these transcripts was detected in the
infected Il17a/ lungs (Figure 3F). These data suggest that after
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B Figure 3. IL-17A Is Required for Induction
of IFN-g Responses during Pulmonary
Tularemia
B6, Il17a/, and Il17ra/ mice were infected with
F. tularensis LVS, and lung G-CSF expression was
determined (A). The percentage of lung neutrophils
in uninfected (UI) or infected B6, Il17a/, and
Il17ra/ mice was determined (B). Lung homoge-
nates from day 6-infected B6, Il17a/, and
Il17ra/ mice were assayed for TNF-a (C), IFN-g
(D). and IL-17A (E). The induction of specific
mRNA was determined by RT-PCR in infected B6
and Il17a/ lungs (F). Data points represent
mean (±SD) from 4–5 mice. *p % 0.05, **p %
0.005, and ***p % 0.0005. One experiment is
representative of two or more.
F. tularensis LVS infection, IL-17A is
important for the induction of G-CSF,
recruitment of neutrophils to the lung,
and generation of protective IL-12-
dependent IFN-g responses.
IL-17A but Not IL-17F or IL-22
Induces IL-12 from DCs
Our in vivo data suggest that IL-17A is
required for induction of IL-12 and IFN-g
responses after pulmonary F. tularensis
LVS infection. DCs are one of the likely producers of IL-12
after stimulation with F. tularensis LVS (Hong et al., 2007).
Therefore, we stimulated bone marrow-derived dendritic cells
(BMDCs) with F. tularensis LVS alone or with IL-17A and
measured IL-12 levels in supernatants. IL-17A treatment of
F. tularensis LVS-stimulated BMDCs resulted in 10-fold induc-
tion of IL-12 in comparison to F. tularensis LVS treatment
alone (Figure 4A). However, IL-17A treatment did not impact
production of other Th17 cell-polarizing cytokines such as IL-6
by F. tularensis LVS-stimulated BMDCs (Figure 4B), suggesting
that F. tularensis LVS by itself was a strong inducer of IL-6. Inter-
estingly, IL-17A treatment alone induced IL-12 production
(Figure 4C) and upregulated reporter IL-12p40 expression in
BMDCs generated from yet40 mice, which express a yellow-
fluorescent protein upon IL-12p40 transcription (Reinhardt
et al., 2006) (Figure S5A). In contrast, IL-22 treatment did
not impact IL-12 production by F. tularensis LVS-stimulated
BMDCs (Figure 4C).
IL-17A and IL-17F share many biological activities but also
have unique biological functions (Chang and Dong, 2009), and
we found that, unlike the addition of IL-17A, the addition of
IL-17F to BMDCs did not induce IL-12 production (Figure 4D).
Moreover, IL-17A but not IL-17F induced the cytokines IFN-g
and IL-6 as well as the chemokines MIP1a and KC in BMDCs,
but did not induce TNF-a (Figure 4D). Furthermore, IL-17A
induced IL-12 and IFN-g in culture supernatants within 1 hr of
treatment (Figure S5B). Thus, IL-17A rather than IL-17F is the
primary mediator of IL-12 and IFN-g expression in DCs.
IL-17R composed of the IL-17RA subunit was initially
identified as the receptor for IL-17A (Yao et al., 1995), but
recently IL-17RA has been shown to partner with IL-17RC802 Immunity 31, 799–810, November 20, 2009 ª2009 Elsevier Inc.
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but not IL-17RC substantially reduced the ability of IL-17A to
induce IL-12, IFN-g, and IL-6 (Figure 4E), as well as chemokines
(data not shown). Therefore, our data suggest that IL-17A, but
not IL-17F or IL-22 can induce the production of IL-12 and
IFN-g in BMDCs and that this induction is independent of
pathogen stimulation but is dependent on IL-17RA. Induction
of IL-12 in macrophages is dependent on IFN-g (Flesch et al.,
1995; Skeen et al., 1996), but DCs may not be subject to
similar regulatory effects (Ma et al., 1997; Schulz et al., 2000).
In support of this, we found that the absence of IFN-g did
not impact the ability of IL-17A to induce IL-12 (Figure S5C).
Further, we also found that sorted lung CD11c+ cells from B6
mice cotreated with F. tularensis LVS and IL-17A induced IL-12
and IFN-g (Figure 4F), but IL-17F treatment did not. Also,
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B C Figure 4. IL-17A but Not IL-17F or IL-22
Can Induce IL-12 from BMDCs
B6 BMDCs were left untreated (UN) and stimulated
with F. tularensis LVS (LVS) alone or with IL-17A
(100 ng/ml), and supernatants were assayed for
IL-12 (A) or IL-6 (B). B6 BMDCs were treated with
F. tularensis LVS (LVS) alone or with IL-22 or
IL-17A (100 ng/ml), or IL-17A (100 ng/ml) alone,
and IL-12 amounts were determined (C). B6
BMDCs were left untreated or treated with IL-17A
(100 ng/ml), IL-17F (100 ng/ml), or both IL-17A
(100 ng/ml) and IL-17F (100 ng/ml), and cytokine
levels were determined in supernatants (D). B6
BMDCs were left untreated or treated with
IL-17A (100 ng/ml) alone or with soluble IL-17RA
(1000 ng/ml) or IL-17RC (1000 ng/ml), and cyto-
kine expression was determined in supernatants
(E). Lung CD11c+ cells from B6 mice were left
untreated or treated with F. tularensis LVS (LVS)
alone or with IL-17A (100 ng/ml) or IL-17F
(100 ng/ml). IL-17A- and IL-17F-treated cultures
were also included, and supernatants were
assayed for IL-12 and IFN-g expression (F).
BMDCs were left untreated (white histogram) or
treated with IL-17A (gray histogram) and expres-
sion of phospho-NF-kb p65 was determined.
Samples were treated in triplicates (A–G) and
data points represent the mean (±SD) (A–F). nd,
not detectable, *p % 0.05, **p % 0.005, and
***p % 0.0005. One experiment is representative
of two or more.
IL-17A induced IL-12 and IFN-g in the
absence of pathogen stimulation in lung
CD11c+ cells (Figure 4F).
IL-17A activates NF-kB, a transcription
factor involved with inflammation (Yao
et al., 1995), and we show that BMDCs
treated with IL-17A resulted in activation
of NF-kB (Figure 4G). Interestingly, addi-
tion of a pharmacological inhibitor of
NF-kB, pyrrolidine derivative of dithiocar-
bamate (PTDC), during IL-17A treatment
of BMDCs resulted in reduction in IFN-g
and IL-6 but did not impact the induction
of IL-12 levels (Figure S5). These data
suggest that IL-17A treatment activates NF-kB in BMDCs and
that some, but not all, downstream events are mediated via
NF-kB signaling.
IL-17A Polarizes IFN-g-Producing T Cells during
F. tularensis LVS Infection
To address whether exogenous IL-17A could impact polarization
of naive T cells into IFN-g-producing cells, we cultured BMDCs
with F. tularensis LVS and with IL-17A, IL-12, or IL-22 and deter-
mined the ability of naive CD4+ OT-II TCR transgenic (Tg) T cells
to differentiate into IFN-g or IL-17A-producing T cells. F. tularen-
sis LVS-stimulated BMDCs increased the number of IFN-g and
IL-17A-producing cells when compared to uninfected BMDC
cultures (Figure 5A). As expected, addition of IL-12 to F. tularen-
sis LVS-stimulated BMDC cultures increased IFN-g-producingImmunity 31, 799–810, November 20, 2009 ª2009 Elsevier Inc. 803
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F. tularensis LVS-alone-treated cultures. Importantly, addition
of IL-17A, but not IL-22, to the F. tularensis LVS-stimulated
BMDCs substantially increased IFN-g-producing cells (Fig-
ure 5A) when compared to F. tularensis LVS-alone-treated
cultures. However, neither IL-17A nor IL-22 influenced the
generation of IL-17A-producing cells relative to F. tularensis
LVS-alone-stimulated cultures. These data demonstrate that
IL-17A can impact Th1 cell immunity during intracellular infec-
tions by priming of naive CD4+ T cells into IFN-g-producing cells.
To address whether IL-17A could induce Th1 cell responses
in a pathogen-free system, we cultured naive OT-II Tg CD4+
T cells with BMDCs, antigen, and IL-17A or IL-12. Addition of
IL-12 to B6 BMDCs resulted in a substantial increase in IFN-g-
producing cells compared to untreated wells (Figure 5C).
Importantly, we show that IL-17A treatment also increased
the number of IFN-g-producing T cells when compared to
untreated cultures (Figure 5C). We then addressed whether
differentiation of IFN-g-producing cells in cultures treated with
IL-17A was mediated via DC-expressed IL-12 and IL-17RA. As
expected, exogenous IL-12 resulted in substantial induction of
IFN-g-producing T cells even when Il12b/ or Il17ra/ BMDCs
were used as APCs (Figures 5D and 5E). Importantly, addition of
IL-17A to Il12b/ or Il17ra/ BMDCs resulted in lower induc-
tion of IFN-g-producing cells when compared to B6 cultures
-
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B Figure 5. IL-17A Can Induce the Polariza-
tion of Naive T Cells into IFN-g-Producing
T Cells
B6 BMDCs were stimulated with F. tularensis
LVS (LVS) alone or with IL-12 (100 ng/ml), IL-22
(100 ng/ml), or IL-17A (100 ng/ml) and naive OT-II
TCR-Tg CD4+ T cells. The frequency of IFN-g (A)
and IL-17A-producing cells (B) were determined
by ELISpot assay. BMDCs generated from B6
mice (C), Il12b/(D), Il17ra/(E), or Ifng/ (F)
were cultured with naive OT-II TCR Tg CD4+
T cells alone or with IL-12 (100 ng/ml) or IL-17A
(100 ng/ml) in triplicates, and IL-17A and IFN-g
expression was determined by flow cytometry.
Fold induction in IL-17A-treated group relative
to untreated control group was determined (G).
Samples were treated in triplicates and data points
represent the mean (±SD). *p% 0.05, **p% 0.005,
and ***p% 0.0005. One experiment is representa-
tive of two or more.
(Figures 5D, 5E, and 5G). Although the
absence of IFN-g in BMDCs did not
impact the IL-17A-dependent IL-12
induction in BMDC cultures (Figure S5C),
we found that Ifng/ BMDCs cocultured
with naive CD4+ OT-II Tg cells and IL-17A
resulted in lower induction of IFN-g-
producing cells when compared to B6
cultures (Figures 5F and 5G). These
data demonstrate that IL-17A mediates
the induction of Th1 cell immunity by
priming of naive CD4+ T cells into
IFN-g-producing cells and that APC-
expressed IL-12, IL-17R, and IFN-g are required for optimal
induction of IFN-g-producing cells.
IL-17A Induces IL-12 and IFN-g in Macrophages
and Enhances Bacterial Clearance
IL-17A was recently shown to induce IL-12 in peritoneal macro-
phages (Ishigame et al., 2009). We found that F. tularensis
LVS treatment induced low amounts of IL-12 in BMDMs
(Figure 6A), but addition of IL-17A to F. tularensis LVS-stimulated
BMDMs resulted in induction of 10-fold more IL-12 compared to
F. tularensis LVS-alone-stimulated cultures (Figure 6A). Further-
more, IL-17A treatment in the absence of pathogen could also
induce IL-12 production in BMDM supernatants (Figure 6A). In
addition, IL-17A could also induce IFN-g and chemokines
MIP-1a and KC (Figure 6A), but not TNF-a in BMDMs (Figure 6A).
In contrast to the effect of IL-17A on BMDCs, cotreatment with
both IL-17A and F. tularensis LVS resulted in synergistic induc-
tion of IL-12, IFN-g, IL-6, MIP1a, and KC in BMDMs. Further,
addition of soluble IL-17RA but not IL-17RC resulted in inhibition
of cytokine and chemokine production (Figure 6A), suggesting
that IL-17A-mediated induction of these molecules in macro-
phages is also mediated by IL-17RA.
IFN-g is documented to enhance the ability of macrophages
to produce IL-12 (Flesch et al., 1995; Skeen et al., 1996).
In support of this, we found that Ifng/ BMDMs induced804 Immunity 31, 799–810, November 20, 2009 ª2009 Elsevier Inc.
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(Figure 6B). Because IL-17A induces IFN-g production in
BMDMs, we next determined whether addition of IL-17A to
BMDMs infected with live F. tularensis LVS would impact intra-
cellular bacterial clearance. As expected, addition of IFN-g to
F. tularensis LVS-infected BMDM cultures resulted in enhanced
bacterial clearance (Figure 6C). Importantly, addition of IL-17A to
F. tularensis LVS-infected BMDMs also resulted in enhanced
bacterial clearance when compared to untreated F. tularensis
LVS-infected BMDM cultures (Figure 6C), and this response
was abrogated when Ifng/ BMDMs were used (Figure 6D).
These data demonstrate that IL-17A can induce IFN-g and
IL-12 production in macrophages and enhance bacterial clear-
ance. Alveolar macrophages are among the first innate cells
that are infected after F. tularensis LVS pulmonary infection
(Hall et al., 2008). Cotreatment of F. tularensis LVS-stimulated
alveolar macrophages with IL-17A, but not IL-17F, resulted in
induction of IL-12 and IFN-g in supernatants when compared
to F. tularensis LVS-alone treatment (Figure 6E). These data
demonstrate that in addition to lung CD11C+ cells, lung alveolar
-γ
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Figure 6. IL-17A Induces IFN-g and IL-12
from Macrophages and Enhances Bacterial
Clearance
BMDMs from B6 mice were either left untreated
(UN) or treated with F. tularensis LVS (LVS) alone,
IL-17A (100 ng/ml) alone, IL-17F alone (100 ng/ml),
or F. tularensis LVS (LVS) and IL-17A (100 ng/ml).
Some wells received IL-17A (100 ng/ml)
and soluble IL-17RA (1000 ng/ml) or IL-17RC
(1000 ng/ml), and protein levels in supernatants
were determined (A). BMDMs from B6 or Ifng/
mice were left untreated or treated with IL-17A
(100 ng/ml), and IL-12 expression was determined
(B). BMDMs from B6 mice (C) or Ifng/ (D) were
infected with live F. tularensis LVS (LVS) alone or
with IFN-g (100 ng/ml) or IL-17A (100 ng/ml) for
24 hr, and intracellular cfu was determined. Lung
alveolar macrophages were treated with F. tular-
ensis LVS (LVS) alone or with IL-17A, IL-17A
(100 ng/ml) alone, or IL-17F alone (100 ng/ml),
and cytokine expression was determined (E).
Samples were treated in triplicates and data
points represent the mean (±SD) (A–E). nd, not
detectable. *p % 0.05, **p % 0.005, and ***p %
0.0005.
macrophages can also induce the pro-
duction of IL-12 and IFN-g in response
to IL-17A.
Cellular Sources of IL-17A
in the Lung after F. tularensis
LVS Infection
To determine the cellular sources of
IL-17A in the lungs of day 6-infected B6
mice, we performed intracellular staining
and flow cytometry. We found that
one of the major producers of IL-17A in
the lungs of F. tularensis LVS-infected
mice was TCRb+ T cells, of which the
majority were CD3+ CD4+ T cells, with some IL-17A-producing
CD8+ T cells. Moreover, gd T cells also produced IL-17A in B6 in-
fected lungs when compared to uninfected lungs (Figure 7A).
Furthermore, purified populations of these cells from infected
B6 lungs showed substantial induction of IL-17A mRNA
(Figure 7B). These data suggest that innate as well as adaptive
immune cells in the lung can produce IL-17A in response to
F. tularensis LVS infection.
Because myeloid cells can respond to IL-17A, we next
determined the expression of IL-17RA and RC mRNA in
BMDCs, BMDMs and purified lung cell populations. We found
high expression of IL-17RA mRNA in myeloid cells such as
DCs, macrophages, and neutrophils, whereas we found lower
expression of IL-17RA mRNA in gd, CD4+, and CD8+ T cells
as well as NK1.1+ cells (Figure 7C). Expression of IL-17RC
mRNA was lower but detectable in both myeloid and lymphoid
populations (Figure 7C). These data suggest that BMDCs,
BMDMs, and lung CD11c+ and alveolar macrophages express
IL-17RA and IL-17RC and therefore can respond to IL-17A
in vivo.Immunity 31, 799–810, November 20, 2009 ª2009 Elsevier Inc. 805
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IL-17A Induces Th1 Cell Immunity during TularemiaOur in vitro data show that IL-17A could induce IL-12 and
IFN-g production in innate cells such as DCs and macrophages
and elicit IL-12-dependent Th1 cell responses in CD4+ T cells
(Figures 4–6). However, the reduced IFN-g protein seen in the
Il17ra/ infected lungs could reflect reduced IFN-g production
in several cell populations. We found that CD4+ and CD8+
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Figure 7. Cellular Sources of IL-17A in the Lung after F. tularensis LVS Infection
Uninfected or F. tularensis LVS-infected B6 (A) mice were assayed for cellular sources of IL-17A-producing cells in day 6-infected lungs by flow cytometry. The
percentage of cells expressing IL-17A within gated populations is shown (A). Log10-fold induction of IL-17A mRNA in sorted lung cell populations from day
6-infected B6 lungs versus uninfected lungs was determined by RT-PCR (B). mRNA expression of IL-17RA or IL-17RC relative to GAPDH expression was deter-
mined by RT-PCR on sorted cell populations (C). The percentage of IFN-g-producing cells within each population in B6 and Il17ra/ infected lungs is shown (D).
Log10-fold induction of IL-12p35 mRNA in sorted cells from infected versus uninfected lungs was determined by RT-PCR (E). F. tularensis LVS-infected Il23a
/ or
Il17a/ mice were treated with PBS or rIL-17, and day 6-infected lung homogenates were assayed for IFN-g and TNF-a (F). The data points represent the mean
(±SD) of values from 3–5 mice (A–F). *p% 0.05, **p% 0.005, and ***p% 0.0005.806 Immunity 31, 799–810, November 20, 2009 ª2009 Elsevier Inc.
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IL-17A Induces Th1 Cell Immunity during TularemiaT cells and NK1.1+ cells produced IFN-g in the B6 infected lungs,
and IFN-g production in these populations was reduced in the
lungs of infected Il17ra/ mice (Figure 7D). These data support
our findings that IL-17A is required for the induction of IFN-g in
CD4+ T cells and also suggests that IL-17A could play a critical
role in eliciting IFN-g expression in other cell types, such as
CD8+ and NK1.1+ cells. Furthermore, CD11c+ cells and neutro-
phils isolated from Il17ra/ infected lungs expressed lower
amounts of IL-12p35 mRNA when compared to cells sorted
from B6 infected lungs (Figure 7E). Because IFN-g was reduced
in the lungs of infected Il17a/ mice when compared to infected
B6 lungs (Figure 3D), we determined whether exogenous
delivery of IL-17A would rescue IFN-g responses in vivo in
Il23a/ and Il17a/ mice. We found that intratracheal delivery
of rIL-17A into infected Il23a/ and Il17a/ mice resulted in
an increase of IFN-g but not TNF-awhen compared to PBS treat-
ment (Figure 7F). These data suggest that IL-17A is required
in vivo for the induction of IFN-g from several cell populations
and exogenous delivery of IL-17A can rescue IFN-g levels in
infected lungs.
DISCUSSION
The IL-23-Th17 cell pathway is critical for protective immunity
against extracellular bacterial infections (Happel et al., 2005;
Ye et al., 2001). However, the IL-23-Th17 cell axis is thought to
be dispensable for protection against intracellular pathogens
(Khader et al., 2005; Schulz et al., 2008; Aujla et al., 2008). We
show that absence of IL-23 and IL-17A but not IL-22 results in
increased susceptibility to pulmonary F. tularensis LVS infection.
We also show that IL-17A can induce IL-12 and IFN-g from DCs
and mediate Th1 cell responses, as well as induce IL-12 and
IFN-g from macrophages and mediate bacterial clearance.
Thus, we demonstrate a unique biological function for IL-17A
in regulating IL-12-Th1 immunity in protection against an intra-
cellular pathogen.
Our data shows that F. tularensis LVS effectively induces the
production of IL-12p40, IL-12 and IL-23 in infected lungs. Similar
to other pulmonary infection models (Happel et al., 2005), early
induction of IL-23p19 and the more sustained production of
IL-12p35 in the F. tularensis LVS-infected lungs suggests that
IL-23 functions during the early immune response. Induction of
IL-23 and IL-17A between days 2-4 may contribute to the
sustained IL-12 mRNA expression detected in infected B6
lungs. Both Th1 and Th17-cell responses are induced in the
lungs of F. tularensis LVS-infected mice, and are dependent
on IL-12p40 cytokines. Specifically, IL-12 is required for Th1
immune responses whereas IL-23 is required for Th17 immune
responses. Further, IL-12 and IFN-g negatively regulate Th17
cell responses in vivo during F. tularensis LVS infection.
However, the failure of high amounts of IL-17A or its inducible
chemokines to protect in the absence of the IL-12-Th1 axis
suggests that the Th17 cell pathway alone cannot confer protec-
tion against pulmonary tularemia.
Our data show that the IL-17A response is antigen-driven and
a majority of the IL-17A-producers were TCRb+ CD3+ and CD4+
T cells, with a smaller population of CD8+ cells. A proportion of
IL-17A-producing cells were detected in wells that did not
receive antigen and are produced by gd T cells in F. tularensisLVS-infected lungs. Furthermore, the fact that Tcrd T cell-defi-
cient mice have reduced expression of IL-17A and are suscep-
tible to pulmonary tularemia suggests that IL-17A produced by
innate cells may serve as a defense mechanism until the adap-
tive immune cells are recruited to control the infection.
Although depletion of neutrophils results in reduced protection
against systemic Francisella infection (Sjostedt et al., 1994),
Francisella can evade neutrophil-killing (Allen and McCaffrey,
2007). Therefore, although decreased recruitment of neutrophils
in the lungs of infected Il17a/ and IL-17ra/ mice may impact
protective immunity against F. tularensis LVS, there is nonethe-
less substantial recruitment of neutrophils in absence of the
IL-17A-IL-17R pathway. This suggests that the increased
susceptibility seen in Il17a/ and IL-17ra/ mice is probably
due to the markedly reduced Th1 cellular responses. We show
that IL-17A, but not IL-17F or IL-22 can enhance the ability
of F. tularensis LVS-stimulated DCs to produce IL-12. This
extends the recent finding that IL-17A can induce the IL-12
production in peritoneal macrophages (Ishigame et al., 2009),
to include BMDCs, BMDMs, lung alveolar macrophages and
lung CD11C+ cells. Importantly, because IL-17A can induce
the production of IL-12 and IFN-g within one hour of treatment,
we conclude that IL-17A dependent induction of IL-12 in APCs
is a rapid event that can impact downstream T cell events. This
pathway may provide the basis for the plasticity of conversion
of Th17 to Th1 responses seen in vivo (Lee et al., 2009), where
it is possible that IL-17A produced by Th17 cells can impact
the induction of IL-12 in APCs and induce the conversion of
Th17 to Th1 cells.
Until recently it was thought that the primary responses to
IL-17A occurred in nonhematopoietic cells such as fibroblast
and epithelial cells (Shen and Gaffen, 2008). However, our
data, as well as data with peritoneal macrophages (Ishigame
et al., 2009), suggest that myeloid cells such as DCs and macro-
phages express substantial amounts of IL-17RA mRNA and
respond to IL-17A by production of cytokines and chemokines.
That this response is mediated primarily through IL-17RA but
not IL-17RC is consistent with studies that show that murine
IL-17RC can only bind to murine IL-17F but not IL-17A, whereas
human IL-17RC can bind to both human IL-17A and IL-17F
(Kuestner et al., 2007). IL-17A is known to activate NF-kb, and
our studies show that IL-17A treatment of BMDCs results in acti-
vation of NF-kb. However, cotreatment with an NF-kb inhibitor
results in loss of some IL-17A-induced cytokines such as
IFN-g and IL-6, but not others such as IL-12. That NF-kb inhibitor
PTDC did not completely repress TLR-driven IL-12 production in
DCs (Bohnenkamp et al., 2007) suggests that other pathways
such as mitogen-activated protein kinases (MAPKs) are
involved. Additional experiments using pathway-specific inhibi-
tors will delineate the signaling pathways involved in IL-17A-
mediated responses in APCs.
An important facet of our findings is that IL-17A can induce
IL-12 and IFN-g production and enhance F. tularensis LVS
bacterial clearance in macrophages. In a Bordetella pertussis
model, it was shown that IL-17A treatment of macrophages
enhanced bacterial clearance (Higgins et al., 2006) and was
thought to be mediated by direct macrophage activation. Our
data suggest that IL-17A-dependent activation of macrophages
and bacterial killing is mediated through induction of IFN-gImmunity 31, 799–810, November 20, 2009 ª2009 Elsevier Inc. 807
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control of bacteria. This suggests that IL-17A can modulate the
innate responses and contribute to immunity and bacterial
clearance until the arrival of adaptive immune cells to the site
of infection.
The fact that IL-17A can induce IL-12 and IFN-g production
from APCs in the absence of pathogen stimulation suggests
that IL-17A acts downstream of the initial pathogen-APC
interaction. Although it is the Th1 cell response that controls
intracellular bacteria, the IL-17A pathway provides critical
‘‘help’’ for induction of the Th1 cell pathway. This is evident
from the reduced IFN-g expression in the lungs of infected
Il17a/ and Il17ra/ mice and the increased IFN-g responses
in infected Il17a/ and Il23a/ mice treated with exogenous
IL-17A. Further proof for IL-17A in generating Th1 cell responses
is reflected by the decreased frequencies of IFN-g-producing
cells and decreased induction of IL-12p35 mRNA in CD11c+
cells and neutrophils in Il17ra/ infected lungs. That IFN-g
production in CD8+ T cells and NK 1.1+ cells is also decreased
in Il17ra/ infected lungs suggests an even broader role for
IL-17A in maintenance of Th1 cell immune responses in the
lung. Recent work shows that IL-17A inhibits T-bet expression
and Th1 cell differentiation in anti-CD3- anti-CD28-stimulated
Th1 cell cultures (O’Connor et al., 2009). However, our data
show that Th cell cultures generated in the presence of APC
and IL-17A can induce Th1 cell responses via induction of
IL-12, suggesting that differential outcomes can be expected
depending on whether the Th1 cell differentiation is mediated
in the presence or absence of DCs.
Absence of the IL-23-Th17 cell axis did not impact IFN-g
responses during M. tuberculosis (Khader et al., 2005) or
L. monocytogenes (Aujla et al., 2008) infections but resulted in
reduced IFN-g responses after M. bovis BCG infection (Ume-
mura et al., 2007). The unique requirement for the IL-23-Th17
cell pathway in induction of Th1 cell responses during F. tularen-
sis LVS and M. bovis BCG but not other intracellular infections is
intriguing. Induction of IL-12 by F. tularensis LVS infection is
dependent on TLR-2 signaling (Hong et al., 2007), whereas
induction of IL-12p40 by a heat-shock protein of Francisella is
dependent on TLR-4 (Ashtekar et al., 2008). M. bovis BCG lipo-
mannans induce IL-12p40 through TLR-2 (Quesniaux et al.,
2004). In contrast, IL-12 production by DCs after M. tuberculosis
infection can take place in the absence of either TLR-2 and
TLR-4 (Jang et al., 2004) and requires signals from both TLR-2
and TLR-9 (Bafica et al., 2005). This suggests that different intra-
cellular bacteria may stimulate differential TLRs on APCs and
produce distinct polarizing cytokines that impact host immune
response to infection. It is likely that some intracellular bacterial
infections can effectively induce IL-12-IFN-g responses in the
host, whereas other pathogens require the IL-23-IL-17A path-
way for effective induction of host IL-12-IFN-g responses for
pathogen control.
In summary, we show that IL-23-dependent IL-17A is induced
during F. tularensis LVS infection and is required for induction of
IL-12, optimal induction of Th1 cell responses, and host resis-
tance to infection. Further studies to understand the unique
requirement for IL-17A in protection against F. tularensis LVS
will advance our understanding of the fundamental requirements
for protective immunity to intracellular pathogens.808 Immunity 31, 799–810, November 20, 2009 ª2009 Elsevier Inc.EXPERIMENTAL PROCEDURES
Animals
C57BL/6 (B6), Il12a/, Il12b/, Ifng/, and yet40 reporter mice, and Tcrd
gene-deficient mice were purchased from The Jackson Laboratory. Il12rb1/
(Piccotti et al., 1999), Il23a/ (Ghilardi et al., 2004), Il12a/.Il23a/ (Khader
et al., 2005), Il17a/ (Nakae et al., 2002), Il17ra/ (Ye et al., 2001), and
Il22/ (Zheng et al., 2008) on the B6 background were used in accordance
with University of Pittsburgh IACUC guidelines.
Experimental Infection, Cytokine, and Antibody Treatment
F. tularensis LVS (BEI Resources) was grown in Mueller-Hinton (MH) broth or
agar (Duckett et al., 2005). For pulmonary infections, mice were infected
intratracheally with 1000 cfu F. tularensis LVS. We prepared heat-inactivated
F. tularensis LVS stocks by incubating bacteria at 60C for 1 hr. Some mice
received recombinant IL-17A (R&D Systems) intratracheally (1.5 mg) on day 3
postinfection. Some B6 mice received 100 mg of isotype control antibody
(501040) or anti-IL-17A (54447, R&D Systems) intraperitoneally on days 2
and 4 postinfection. Serial dilutions of homogenized infected lungs were plated
on day 6 so that lung cfus could be determined.
Cell Preparation
Lung cell suspensions were prepared as described before (Khader et al.,
2005) and used for ELISpot, flow cytometric analyses or for sorting purified
populations.
Detection of Cytokine Producing Cells by ELISpot Assay
Detection of antigen-specific IFN-g- and IL-17A-producing cells was carried
out with an ELISpot assay (Khader et al., 2005). F. tularensis LVS heat-inacti-
vated antigen (0.5 mg/ml, BEI Resources) or OVA323-339 peptide (5 mM) was
used for stimulating cells from F. tularensis LVS-infected or OT-II TCRab Tg
mice, respectively.
Generation and Stimulation of BMDMs and BMDCs
BMDMs and BMDCs were generated from the bone marrow cells (Khader
et al., 2005) by culturing in cDMEM containing GM-CSF (PeproTech). On
day 7, nonadherent cells were used as BMDCs, and adherent cells were
used as BMDMs. Lung alveolar macrophages were obtained by bronchoal-
veolar lavage. Cells were stimulated with heat-inactivated F. tularensis
LVS (MOI 1:100) alone or in combination with 100 ng/ml IL-17A, 100 ng/ml
IL-17F, or 100 ng/ml IL-22 and either 1000 ng/ml soluble IL-17RA Fc chimera
or 1000 ng/ml soluble IL-17RC (R&D Systems). In some experiments, the
BMDCs were pretreated with a NF-kb inhibitor PTDC (100 mM) for 45 min
and then cotreated with IL-17A for 45 min. Culture supernatants were analyzed
by luminex assays. For macrophage killing assays, BMDMs were infected
with live F. tularensis LVS (MOI 1:10) for 24 hr in the presence of either
100 ng/ml IFN-g or 100 ng/ml IL-17A in antibiotic-free cDMEM. BMDMs
were washed extensively, lysed with sterile water, and serially diluted, and
cfu was determined.
Determination of Protein Amounts
IL-17A, IL-12, IFN-g, TNF-a, IL-6, G-CSF, GM-CSF, KC, MIP-1a, MCP-1, IL-1a,
and IL-1b protein amounts were measured in lung homogenates and cell
culture supernatants with a 22-plex mouse Luminex assay (Linco/Millipore).
Naive CD4+ T Cell Isolation and In Vitro Effector Generation
Naive CD4+ T cells were isolated from OT-II TCRab Tg mice with magnetic
CD4+ beads (GK1.5) (Miltenyi Biotec) and purified on the basis of CD62Lhi
and CD25lo expression on a BD FACSAria (>98%). Naive OT-II CD4+ T cells
(1 3 106 cells/ml) were cultured with F. tularensis LVS-stimulated or unstimu-
lated BMDCs (1 3 106 cells/ml) and OVA323–339 peptide (5 mM) for 6 days. In
some wells IL-12, IL-17A, or IL-22 (100 ng/ml) were added. At the end of the
culture period, the numbers of IFN-g- or IL-17A-producing CD4+ T cells was
determined by ELISpot assay or intracellular staining.
Flow Cytometry and Cell Sorting
Single-cell suspensions were stained with fluorochrome-labeled antibodies
specific for CD3 (17A2), CD4 (RM4-5), CD8 (53-6.7), TCRb (H57-597), TCRgd
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IL-17A Induces Th1 Cell Immunity during Tularemia(GL3), NK1.1 (PK136), Gr1 (RB6-8C5), CD11b (M1/70), CD11c (HL3), and MHC
class II I-Ab (AF6-120.1). For intracellular analyses of cells, cells stimulated with
Phorbol myristate acetate (50 ng/ml), ionomycin (750 ng/ml; Sigma Aldrich),
and Golgistop (BD PharMingen), surface stained, permeabilized with Cyto-
fix-Cytoperm solution (BD PharMingen), and stained with anti-IFN-g
(XMG1.2) and anti-IL-17A (TC11-18H10). For determining activation of
NF-kB with the phospho-NF-kB p65 (3H1, Cell Signaling), cells were stained
in accordance with the manufacturer’s instructions. For purified lung popula-
tion sorting, stained cells were sorted on BD FACS Aria flow cytometer
as CD3+ CD4+ (>94%), CD3+ CD8+ (>96%), and CD11b+Gr1+ neutrophils
(>95%). For other sorts, CD11C+ (>91%) cells, gd (>84%) cells, and NK1.1
(>93%) cells were sorted on the basis of respective staining. For analysis,
FlowJo (Tree Star) was used.
Real-Time PCR
RNA was extracted (Khader et al., 2005), reverse transcribed, and amplified
with FAM-labeled probe and primers on the ABI Prism 7700 detection system.
The fold increase in signal over that derived from uninfected samples was
determined with the DDct calculation. The primer and probes sequences
have been previously published (Khader et al., 2005) or were commercially
purchased (ABI Biosystems).
Statistical Analysis
Differences between the means of groups were analyzed with the two-tailed
Student’s t test in GraphPad Prism 4. Inherently logarithmic data from bacterial
growth and RT-PCR were transformed for statistical analyses.
SUPPLEMENTAL DATA
Supplemental Data include five figures and can be found with this article online
at http://www.cell.com/immunity/supplemental/S1074-7613(09)00448-8.
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